So I think it looks very good. A new investor, two new directors and a good pipeline:
"In addition to its portfolio of intellectual property and early-stage product candidates, MacroChem has two clinical-stage product candidates containing its patented enhancer, SEPA(R): Opterone(R), a topical cream for male testosterone deficiency, and EcoNail(TM), a SEPA-enhanced antifungal nail lacquer to treat a common and potentially debilitating nail infection known as onychomycosis."
It doesn´t look like they want to sell all their assets any more.
The investor knows why he invested 2.5 Million Dollar!
